medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2006, Number 4

<< Back Next >>

Rev Mex Oftalmol 2006; 80 (4)

Tomografía de coherencia óptica macular para detección temprana de daño glaucomatoso

Ortega-Santana JF, Ayala-Flores JM, García-López A

Language: Spanish
References: 19
Page: 191-194
PDF size: 45.52 Kb.


ABSTRACT

Purpose: To evaluate if the optical coherence tomography measurement of macular thickness is useful in the early detection of glaucomatous damage.
Methods: We used optical coherence tomography to measure macular thickness in glaucoma suspects and compared these results between the group of patients who had normal frequency doubling technology and those who had not.
Results: Of 22 eyes, 18 had normal frequency doubling technology results (Group1), and 4 had abnormal results (Group 2). The mean age was 47.89 years for the first group and 45.25 years for the second, p = 0.777. No statistically significant difference of intraocular pressure or cup/disc ratio was found between both groups. We did not find statically significant difference of macular thickness measured with optical coherence tomography in any area of the retinal map between the two groups.
Conclusions: Macular thickness measured by optical coherence tomography didn’t show a statically significant difference between both groups. We conclude that macular optical coherence tomography analysis isn’t useful for early detection of glaucomatous damage.


REFERENCES

  1. Tasman, Jager. Duane’s Clinical Ophthalmology on CDROM. 2003. Lippincott, Williams & Wilkins. 2003.

  2. American Academy of Ophthalmology. Glaucoma. Curso de Ciencias Básicas y Clínicas. Lifelong Education for the Ophthalmologist. Edición 1998-1999.

  3. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophalmol. 1982; 100:135-146.

  4. Ritch R. The Glaucomas. Basic Sciences. Second Edition. Mosby, USA, 1996.

  5. Yanoff M. Ophthalmology. Mosby, London UK. 1999.

  6. Zeimer R, Asrani S, Zou S y col. Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping. A pilot study. Ophthalmology 1998; 105:224-31.

  7. Boyd B, Lantz M. Últimas innovaciones en los glaucomas. Etiología, diagnóstico y tratamiento. Highlights of Ophthalmology. Bogotá, Colombia. 2002.

  8. Hee MR, Izatt JA, Swanson EA y col. Optical coherence tomography of the human retina. Arch Opthalmol 1995;113:325-332.

  9. Carl Zeiss Ophthalmic Systems, Inc. Optical Coherence Tomographer Model 3000. User Manual. Germany, 2002.

  10. Gudes V, Schuman JS, Hertzmark E, Wollsrein G y cols. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmolgy 2003; 110:177-189.

  11. Schuman JS, Hee MR y cols. Quantificarion of the nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthal 1995; 113:586-596.

  12. Carpineto P, Cinacaglini M, Zuppardi E, Falconio G y cols. Realibility of nerve fiber layer thickness measurement using optical coherence tomography in normal and glaucomatous eyes. Ophthalmology 2003; 110:190-195.

  13. Alward WL. Frecuency doubling technology perimetry for the detection of glaucomatous visual field loss. Am J Ophthalmol 2000; 129:376-378.

  14. CelloKE, Nelson-Quigg JM, Johnson CA. Frecuency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 2000; 129:314-322.

  15. Horani A, Frenkel S, Yahalom C, Farber MD y col. The learning effect in visual field testing of healthy subjects using frequency doubling technology. J Glaucoma 2002; 11:6.

  16. Quigley HA, Dunkelberg GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988; 95:357-363.

  17. Wallace LM. Glaucoma. Los Requisitos en Oftalmología. Editorial Harcourt Mosby, España, 2001.

  18. Choplin NT. Visual field testing with the Humphrey field analyzer. Second Edition. Slack Icorporated, USA, 1999.

  19. Hodapp E, Parrish RK, Anderson DR. The asymptomatic patient with elevated pressure. Clinical Decisions in Glaucoma. St Louis. CV Mosby, 1993.




2020     |     www.medigraphic.com